Progression-free survival in bevacizumab-based first-line treatment for patients with metastatic colorectal cancer: is it a really good end point?
- PMID: 19720898
- DOI: 10.1200/JCO.2009.23.1050
Progression-free survival in bevacizumab-based first-line treatment for patients with metastatic colorectal cancer: is it a really good end point?
Comment on
-
Surrogate end points for median overall survival in metastatic colorectal cancer: literature-based analysis from 39 randomized controlled trials of first-line chemotherapy.J Clin Oncol. 2007 Oct 10;25(29):4562-8. doi: 10.1200/JCO.2006.08.1935. Epub 2007 Sep 17. J Clin Oncol. 2007. PMID: 17876010 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
